BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 608570)

  • 1. Clinical studies on dissolution of gallstones using ursodeoxycholic acid.
    Okumura M; Tanikawa K; Chúman Y; Kóji T; Nakagawa S; Nakamura Y; Iino H; Yamasaki S; Hisatsugu T
    Gastroenterol Jpn; 1977; 12(6):469-75. PubMed ID: 608570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.
    Roda E; Bazzoli F; Labate AM; Mazzella G; Roda A; Sama C; Festi D; Aldini R; Taroni F; Barbara L
    Hepatology; 1982; 2(6):804-10. PubMed ID: 7141392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
    Iwamura K
    Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
    Meredith TJ; Williams GV; Maton PN; Murphy GM; Saxton HM; Dowling RH
    Gut; 1982 May; 23(5):382-9. PubMed ID: 7076015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial.
    Polli EE; Bianchi PA; Conte D; Sironi L
    Digestion; 1981; 22(4):185-91. PubMed ID: 7030835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
    Leiss O; von Bergmann K
    Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid.
    Erlinger S; Le Go A; Husson JM; Fevery J
    Hepatology; 1984; 4(2):308-14. PubMed ID: 6706305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired gallstone opacification during cholelitholytic treatment with chenodeoxyholic, ursodeoxycholic, and tauroursodeoxycholic acids.
    Bazzoli F; Festi D; Mazzella G; Frabboni R; Zagari RM; Fossi S; Pozzato P; Sottili S; Simoni P; Roda A
    Am J Gastroenterol; 1995 Jun; 90(6):978-81. PubMed ID: 7771434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
    Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
    Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Per oral gallstone dissolution therapy].
    Sugata F
    Nihon Rinsho; 1993 Jul; 51(7):1785-90. PubMed ID: 8366596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials.
    May GR; Sutherland LR; Shaffer EA
    Aliment Pharmacol Ther; 1993 Apr; 7(2):139-48. PubMed ID: 8485266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses.
    Podda M; Zuin M; Carulli N; Ponz de Leon M; Dioguardi ML
    J Int Med Res; 1982; 10(1):59-63. PubMed ID: 7060825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Magnesium Trihydrate of Ursodeoxycholic Acid and Chenodeoxycholic Acid for Gallstone Dissolution: A Prospective Multicenter Trial.
    Hyun JJ; Lee HS; Kim CD; Dong SH; Lee SO; Ryu JK; Lee DH; Jeong S; Kim TN; Lee J; Koh DH; Park ET; Lee IS; Yoo BM; Kim JH
    Gut Liver; 2015 Jul; 9(4):547-55. PubMed ID: 26087862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimum bile acid treatment for rapid gall stone dissolution.
    Jazrawi RP; Pigozzi MG; Galatola G; Lanzini A; Northfield TC
    Gut; 1992 Mar; 33(3):381-6. PubMed ID: 1568660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients.
    Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Barbara L
    Dig Dis Sci; 1979 Feb; 24(2):123-8. PubMed ID: 428300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison on Response and Dissolution Rates Between Ursodeoxycholic Acid Alone or in Combination With Chenodeoxycholic Acid for Gallstone Dissolution According to Stone Density on CT Scan: Strobe Compliant Observation Study.
    Lee JM; Hyun JJ; Choi IY; Yeom SK; Kim SY; Jung SW; Jung YK; Koo JS; Yim HJ; Lee HS; Lee SW; Kim CD
    Medicine (Baltimore); 2015 Dec; 94(50):e2037. PubMed ID: 26683912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallstone dissolution--a progress report.
    Pearlman BJ; Marks JW; Bonorris GG; Schoenfield LJ
    Clin Gastroenterol; 1979 Jan; 8(1):123-40. PubMed ID: 369742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence.
    Maton PN; Iser JH; Reuben A; Saxton HM; Murphy GM; Dowling RH
    Medicine (Baltimore); 1982 Mar; 61(2):86-97. PubMed ID: 7062856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution of cholesterol gallstones by ursodeoxycholic acid.
    Nakagawa S; Makino I; Ishizaki T; Dohi I
    Lancet; 1977 Aug; 2(8034):367-9. PubMed ID: 70585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy.
    Walters JR; Hood KA; Gleeson D; Ellul JP; Keightley A; Murphy GM; Dowling RH
    Gut; 1992 Mar; 33(3):375-80. PubMed ID: 1568659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.